EIM
ANIP icon

Essex Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

Essex Investment Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-39,376
Closed -$1.23M – 354
2014
Q1 		$1.23M Sell
39,376
-37,584
-49% -$997K 0.18% 175
2013
Q4 		$1.54M Buy
+76,960
New +$998K 0.22% 139

Other funds holding ANIP

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

Essex Investment Management's ANIP Position: Q2 2014 in Review

Essex Investment Management sold out of ANI Pharmaceuticals (ANIP) in Q2 2014, closing a stake of 39,376 shares — an estimated $1.23M sold.

Essex Investment Management first reported a position in ANIP in Q4 2013 and held it in 2 quarters. The position peaked at $1.54M in Q4 2013. 81 funds tracked by Wall St. Rank hold ANIP as of Q2 2014.

  • Essex Investment Management reported no remaining ANI Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Essex Investment Management sold 39,376 ANI Pharmaceuticals shares in Q2 2014, an estimated $1.23M.
  • Essex Investment Management first reported a position in ANI Pharmaceuticals in Q4 2013 and held it in 2 quarters.
  • Essex Investment Management's ANI Pharmaceuticals position peaked at $1.54M in Q4 2013.
  • 81 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2014.

Based on Essex Investment Management's 13F filing for Q2 2014, filed 23 Jul 2014.